Brain Computer Interface technologies are in constant improvement with interaction modalities ranging from non-invasive (EEG, TMS, etc.) to chronically implanted devices. We are presenting here Kiwi, a novel, minimally invasive micro-implant using nanotechnologies to record the electrical activity of neural tissue and stimulate using electrical and optical stimulation modalities. Kiwi micro-implant is operating wirelessly and is coupled to a cutting-edge AI module providing the possibility to detect in real-time neural activity patterns and adjust the stimulation parameters accordingly. This adaptative, minimally invasive and smart BCI opens a new way for personalized therapeutic applications in numerous diseases such as neurodegenerative diseases (Parkinsons, Alzheimers, etc.), mental illnesses (depression, anxiety, etc.) or chronic pain, brain augmentation and research device.

This panel discussion will examine the current landscape of mergers and acquisitions with the sensors and device space. Our panel of experts will discuss the current outlook within the marketplace and will examine past success and failures and how the pitfalls of failure can be avoided.